A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

THOUSAND OAKS, Calif., Oct. 24, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

Amgen AMGN will report third-quarter 2024 results on Oct. 30, after market close. In the last reported quarter, the company ...

On Tuesday, Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $319.66 which represents a slight increase of $2.92 or 0.92% from the prior close of $316.74. The stock opened at $315.24 and ...

USA News Group News Commentary – With over 100 million Americans facing obesity and rates rising globally, it’s no surprise ...

WILMETTE, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today ...

Ionis has five FDA-approved drugs and promising upcoming approvals. See more about IONS stock and why it warrants a Buy ...

The latest trading session saw Amgen (AMGN) ending at $314.90, denoting a -1.49% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.92%. On the ...

Novo Nordisk and Eli Lilly still have first-mover advantage, but Roche, Pfizer and others all have similar products in the ...

Calling the decision not to disclose the genetic results “certainly troubling” and “ethically fraught,” George Perry, editor ...

Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...